PRF1 and malignant colon neoplasm: There is data suggesting that adoptive chimeric antigen-receptor-modified NK-cells transfected with EpCAM gene selectively targets EpCAM-expressing colon cancer cells with a release of interferon (IFN)-γ, perforin and granzyme-B and specific cytotoxicity [33].